IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·
← Today’s Receipts
Public-record receiptD-NJOfficial filing linked

Josh Gottheimer disclosed BUY $V

Here’s the public record: who traded, what they disclosed, when it happened, how late it appeared, and what context is attached.

Trade range
$1K – $15K
Filed
2025-02-10
Trade date
2025-01-31
Disclosure lag
10 days after trade

Why this receipt matters

A quick read before you share it.

These are factual context points from the receipt and linked public-record data. They explain why the disclosure may be worth opening, not whether anyone acted improperly.

Official public filing linked
1The receipt links to an official public filing, so readers can verify the underlying disclosure before sharing.
2The filing appeared 10 days after trade, which helps separate trade timing from filing timing.
3The disclosed range is $1K – $15K, which is the public reporting band rather than an exact profit or loss figure.
413 nearby same-ticker disclosures appeared in the surrounding 30-day window.
5Committee context is available for Josh Gottheimer, but PoliWealth treats it as context - not proof of intent or wrongdoing.
6Related public-record context includes 13 lobbying filings.

Source

Official filing ↗
Source: official House/Senate financial disclosure record · filing ID 20026732 · filed 2025-02-10 · disclosed 10d after transaction

Market context

Visa Inc.

Sector: Financials

Vs SPY: -27.1%

Factual flags

  • 13 lobbying filings linked to this ticker.
  • 13 nearby same-ticker disclosures in the surrounding 30-day window.
  • 80 trades filed on 2025-02-10 (batch dump)

Member trail

Josh Gottheimer

U.S. House · NJ-5

House Permanent Select Committee on IntelligenceHouse Committee on Financial Services

Ticker trail

$V

Visa Inc.

Follow this ticker

Alert me when this ticker gets a new congressional receipt. This page reports public disclosures and factual context only. It does not determine intent, is not an accusation, and is not investment advice.